التفاصيل البيبلوغرافية
| العنوان: |
Migratory Pulmonary Infiltrates in a B-Cell-Depleted COVID-19 Patient. |
| المؤلفون: |
Zhu, Wenyan, Xie, Tiange, Xu, Mengru, Chen, Ruxuan, Zhang, Ting |
| المصدر: |
Infection & Drug Resistance; Nov2023, Vol. 16, p7205-7208, 4p |
| مصطلحات موضوعية: |
SARS-CoV-2, COVID-19, CONVALESCENT plasma |
| مستخلص: |
Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still rampant around the world. Immunocompromised patients are prone to have long-term infection with coronavirus disease 2019 (COVID-19). However, it is difficult to decide on an appropriate treatment for persistent SARS-CoV-2 infection.Case Presentation: We present a case of prolonged SARS-CoV-2 infection in a patient who had undergone B-cell depletion therapy. Chest computed tomography (CT) revealed notable migratory pulmonary infiltrates, and bronchoalveolar lavage fluid was positive for SARS-CoV-2 (day-120). The patient responded well to the combination treatment of antiviral medication, convalescent plasma, and corticosteroid.Conclusion: When chest CT shows migratory pulmonary infiltrates in patients with recent COVID-19, it is necessary to be alert to the possibility of persistent SARS-CoV-2 infection, especially in B-cell-depleted immunocompromised patients. Once the diagnosis is confirmed, repeated antiviral therapy and intravenous convalescent plasma should be considered. [ABSTRACT FROM AUTHOR] |
|
Copyright of Infection & Drug Resistance is the property of Dove Medical Press Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder